ALKS Greeks

Option Greeks measure how Alkermes Inc plc (ALKS) option prices respond to changes in the stock price (delta and gamma), the passage of time (theta), implied volatility (vega), and interest rates (rho). These charts plot each Greek by strike, so you can see where an expiration's price risk, time decay, and volatility exposure are concentrated. ALKS implied volatility is near the bottom of its one-year range, which keeps delta and gamma in a narrower range of strikes than usual.

Upgrade to view higher order greeks (Vanna, Charm, and Vomma) and multiple expiration dates.

Upgrade now

       

ALKS Option Greeks FAQ

What are option Greeks?

Option Greeks measure how an option's price responds to changes in the stock price (delta and gamma), time (theta), implied volatility (vega), and interest rates (rho).

How do I read the ALKS Greeks charts?

Gamma, theta, and vega are largest for strikes near the Alkermes stock price and shrink for strikes far above or below it. Theta grows as expiration gets closer, while vega is larger for expirations further out. Call delta runs from 0 to 1 and put delta from -1 to 0, near 0.50 and -0.50 at the money, and roughly estimates the chance that an option finishes in the money.

How does implied volatility affect ALKS's Greeks?

Alkermes IV rank is 13, so implied volatility is near the bottom of its one-year range. Higher implied volatility raises option premiums and daily time decay (theta), and spreads delta and gamma across a wider range of strikes. Over the past year, 30-day implied volatility ranged from 30.0% to 188.8%. See the ALKS implied volatility history for a longer view.

How much gamma and delta do ALKS options carry in total?

Across all open Alkermes options on Nov 4, 2026, net gamma exposure was $263.95K and net delta exposure was $4.06M per 1% move in the stock. The ALKS gamma exposure chart shows where that gamma sits by strike.

What is Alkermes Inc plc?

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas.

Give feedback on this chart